[Peroral antithrombotic treatment].
Petersen
Palle
P
Andersen
Grethe
G
Husted
Steen E
SE
Boysen
Gudrun
G
Johnsen
Søren Paaske
SP
D000284:Administration, Oral; D000933:Antifibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D020521:Stroke / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000933:Antifibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K; D004176:Dipyridamole; D001241:Aspirin